Andere Sprachen Navamedic ASA

Aktien

A0JKUU

NO0010205966

NAVA

Pharmazeutika

Markt geschlossen - Oslo Bors Andere Börsenplätze 16:45:00 12.02.2026			% 5 Tage	Veränd. 1. Jan.
21,70 ^NOK	-2,69 %		-1,81 %	-8,82 %

07.01.	Navamedic ASA Bestätigt Vorstandsernennungen	CI
07.01.	Navamedic EGM wählt Morten Jurs zum Vorstandsvorsitzenden	RE

Andere Sprachen

12.02.	Navamedic ASA: Strong growth and important product launch in Q4 2025
09.02.	Navamedic ASA: Invitation to presentation of fourth quarter 2025 results
13.01.	Navamedic : Minutes EGM January 2026
07.01.	Navamedic ASA Approves Board Appointments
07.01.	Navamedic EGM elects Morten Jurs as chair of board
07.01.	Navamedic ASA: Minutes of Extraordinary General Meeting
12.12.	Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026
09.12.	Oslo, December 9, 2025 - Navamedic ASA Introduces Flexilev[®] in OraFID[®]: Enhancing Parkinson's Care with Simplified and Precise Dosing for Personalized Treatment
08.12.	Navamedic Names New Finance Chief
08.12.	Navamedic appoints Nils Ole Krekling as CFO
08.12.	Navamedic ASA: Appointment of CFO
08.12.	Navamedic ASA Appoints Nils Ole Krekling as Chief Financial Officer, Effective January 1, 2026
28.11.	Pharmaceutical Company Navamedic's CFO Steps Down
28.11.	Navamedic ASA Announces CFO Changes
28.11.	Navamedic says CFO Lars Hjarrand to step down
28.11.	Navamedic ASA: Resignation of CFO
28.10.25	Navamedic ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
28.10.25	Navamedic Q3 adjusted EBITDA NOK 11.3 mln
28.10.25	Navamedic reiterates mid-term ambition of building NOK 1 billion revenue co
28.10.25	Navamedic ASA: Double digit growth in the 3rd quarter, 2025
28.10.25	Navamedic ASA: Double digit growth in the 3rd quarter, 2025
24.10.25	Navamedic ASA: Invitation to 2025 3rd quarter presentation
17.10.25	Navamedic ASA and Evolsin Medical Sign Exclusive Distribution Agreement for Germany
17.10.25	Navamedic and Evolsin sign exclusive distribution deal for Germany
17.10.25	Navamedic Enlists Evolsin for German Distribution of Antiperspirant Product

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Andere Sprachen Navamedic ASA

Aktien

A0JKUU

NO0010205966

NAVA

Pharmazeutika

Andere Sprachen

Filter